JHL Biotech Presents at 2015 Biopharma Development and Production Conference20 May 2015
KC Carswell, Ph.D. Sr. Director of Process Development of JHL presented “An Approach to Biosimilar Development” at the conference in Shanghai on May 20, 2015
David Kapitula, Vice President of Quality and Regulatory Affairs shared the stage with Yariv Hefez, VP BD Biosimilar Portfolio Merck, and the CEO of Boston Oncology at the Keynote Panel: Global Biopharma Outlook: Opportunities and Challenges 2015 and Beyond.
The Biopharma Development & Production Week took place from 19th May to the 22th May 2015 at Shanghai, China. Guests of the conference are industry leaders, researchers and professionals from the Biopharma Industry, Biosimilar Medicines and Biological Sciences community. It attracted more than 300 attendees from over 19 countries. Attendees included Merck and Pfizer, etc.